You are here: Industry Insights > AMD

News List

Novartis launches review of Beovu after safety concerns, says report europeanpharmaceuticalreview
March 04, 2020
An external review of the medicine Beovu has been announced by Novartis, which produces the drug, according to a new report.
Kodiak Sciences Receives Positive Phase I Data contractpharma
July 31, 2019
Phase 1b study complete for KSI-301, treatment of (wet) AMD, DME, and RVO.
First patient recruited in global AMD trial pharmatimes
April 24, 2019
A global research trial involving a new treatment to tackle early stage dry age-related macular degeneration (AMD), which causes blindness, has been launched.
Novartis Announces FDA Filing Acceptance and Priority Review of Brolucizumab (RTH258) for Patients with Wet AMD drugs
April 17, 2019
Novartis Announces FDA Filing Acceptance and Priority Review of Brolucizumab (RTH258) for Patients with Wet AMD.
Protect Your Aging Eyes From Macular Degeneration drugs
February 18, 2019
Age-related macular degeneration (AMD) is an incurable eye disease that affects millions of older Americans, but there are a number of things you can do to reduce your risk, a vision expert says....
Stealth BioTherapeutics Granted Fast Track Designation for Elamipretide americanpharmaceuticalreview
December 11, 2018
Stealth BioTherapeutics announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for its lead investigational candidate, elamipretide....
Italy free to reimburse off-label Avastin, rules EU court pharmaphorum
November 28, 2018
Novartis and Roche’s long-running battle to try to prevent off-label prescribing of Roche’s Avastin in place of their approved Lucentis product for the eye disease age-related macular degeneration (AMD) has been dealt a blow by the European Court of Justi
Compact Imaging Collaborates with Global Pharma to Accelerate Development of Home Monitor pharmafocusasia
November 28, 2018
Compact Imaging, Inc. (CI), a developer of miniaturized optical coherence tomography (OCT) devices, today announced the signing of a collaboration agreement with......
Common diabetes drug can protect against age-related macular degeneration, research shows pharmafile
November 01, 2018
A Taiwan, Chinaese research team has demonstrated a link between the use of the common diabetes medication metformin and significantly lower rates of age-related macular degeneration (AMD) – the leading cause of blindness ...
Two-year AMD study data reaffirm superiority of Novartis' brolucizumab at reducing retinal fluid, thickness versus Regeneron's Eylea firstwordpharma
October 29, 2018
Two-year AMD study data reaffirm superiority of Novartis' brolucizumab at reducing retinal fluid, thickness versus Regeneron's Eylea

Previous page 1 2 3 Next page